SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-23-053956
Filing Date
2023-07-03
Accepted
2023-07-03 13:11:54
Documents
14
Period of Report
2023-07-03
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea181281-8k425_phoenix.htm   iXBRL 8-K 50021
2 PROXY SUPPLEMENT, DATED JULY 3, 2023 ea181281ex99-1_phoenix.htm EX-99.1 15610
  Complete submission text file 0001213900-23-053956.txt   299742

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE pbax-20230703.xsd EX-101.SCH 4097
4 XBRL DEFINITION FILE pbax-20230703_def.xml EX-101.DEF 27266
5 XBRL LABEL FILE pbax-20230703_lab.xml EX-101.LAB 37791
6 XBRL PRESENTATION FILE pbax-20230703_pre.xml EX-101.PRE 25886
8 EXTRACTED XBRL INSTANCE DOCUMENT ea181281-8k425_phoenix_htm.xml XML 7053
Mailing Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3400 PHILADELPHIA PA 19103 2157319450
PHOENIX BIOTECH ACQUISITION CORP. (Filer) CIK: 0001870404 (see all company filings)

IRS No.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40877 | Film No.: 231064416
SIC: 2836 Biological Products, (No Diagnostic Substances)